Description:

S1007 Adverse Event Summary Form Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90DA93B9-537E-5D33-E040-BB89AD434FA6

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90DA93B9-537E-5D33-E040-BB89AD434FA6

Keywords:
Versions (4) ▾
  1. 8/27/12
  2. 1/8/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT01272037 Toxicity - S1007 Adverse Event Summary Form - 3140849v1.0

Instructions: Please complete this form at 6 months, 1 year, 2 years, and 3 years after randomization. Report Grades 3-5 adverse events only. Document the worst Grade seen during the reporting period. Do not code a condition existing prior to registration as an adverse event unless it worsens. Category lists may not include all adverse events from that category. Record any observed adverse events not listed on the blank lines at the end. All dates are MONTH, DAY, YEAR. Explain any blank dates or fields in the Comments section. Place an X in appropriate boxes. Circle AMENDED items in red and write AMENDED across top of form

Header
Reporting Period
Adverse Events
Were adverse events assessed during this time period?
CTC Adverse Event Term
CTC AE Grade (4.0 3-5)
CTC Adverse Event Attribution Code
Comments

Similar models